Stevanato Group S.p.A.

NYSE:STVN

Medical - Instruments & Supplies

Healthcare
$15.36 +3.90%

+$0.67 today

Market cap
$4.20B
Beta
0.78
P/E (TTM)
29.9
EPS (TTM)
$0.52
Dividend yield
0.35%
52W Low $12.89High $28.00

Volume 0.61M

Average 0.52M

STVN Other Financing Activities

Financing cash flows not reported separately.

Stevanato Group S.p.A.NYSE: STVN

Other Financing Activities · Q2 FY2026 · quarter ended Jun 2026

Other financing activities outflow grows to €0

Q2 FY2026 other financing activities was €0, compared with €0 a year earlier. Trailing-twelve-month other financing activities was -€14.98M.

Context

  • Other financing activities amounted to 0.5% of revenue in FY2025, up 0.5 pp from a year earlier.
  • Other financing activities increased in 1 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly other financing activities holds near €0 or moves back toward the trailing-twelve-month quarterly average of -€3.74M.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterJun 2026
€0— QoQ
Last fiscal yearDec 2025
-€6.03M— YoY
LTMJun 2026
-€14.98M— YoY
Other Financing Activities past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Other Financing Activities history

EUR · from the cash flow

Latest · FY2025
(6.03M) EUR
Year-over-year change
—

Other Financing Activities vs competitors

How STVN compares with its peers on the latest reported figures

  • Peers report in different currencies, so other financing activities is compared through growth and share of revenue rather than absolute size.
  • Other financing activities amounts to 1.2% of revenue for STVN, versus a peer median of 0.3%.
STVN Competitors
Other Financing Activities for STVN and competitors
Company Period LTM YoY 3-year CAGR% of revenue
TFXTeleflex IncorporatedLTM Jun 2026$153.13M USD-1981.7%+7.4%5.9%
AXSMAxsome Therapeutics, Inc.LTM Jun 2026$25.78M USD-213.6%+59.8%3.3%
CHEChemed CorporationLTM Jun 2026$19.73M USD-40.1%—0.8%
BTSGBrightSpring Health Services, Inc. Common StockLTM Sep 2026$19.14M USD-932.1%+38.1%0.1%
MASIMasimo CorporationLTM Apr 2026$16.1M USD-10.1%-6.7%1.0%
AVTRAvantor, Inc.LTM Jun 2026$15.2M USD-172.4%—0.2%
STVNStevanato Group S.p.A.LTM Jun 2026€14.98M EUR——1.2%
ATRAptarGroup, Inc.LTM Jun 2026$7.93M USD-78.9%—0.2%
MMSIMerit Medical Systems, Inc.LTM Sep 2026$5.6M USD-50.5%-29.9%0.3%
BLCOBausch + Lomb CorporationLTM Jun 2026$499.55K USD-98.7%-78.4%0.0%
NUVLNuvalent, Inc.LTM Mar 2026$0 USD+100.0%——
Peer median (excluding STVN) —-88.8%+0.3%0.3%

Competitors are the stored peer set for STVN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

EUR
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income165.67M187.64M189.55M160.29M134.32M
Depreciation & Amortization56.38M64.82M78.48M80.65M88.57M
Deferred Income Tax00000
Stock-Based Compensation00000
Change in Working Capital(41.63M)(117.74M)(102.48M)(17.41M)48.63M
Accounts Receivables(54.77M)(46.42M)(93.86M)(3.83M)855.83K
Inventory(31.2M)(107.37M)(113.59M)12.31M(39.82M)
Accounts Payables44.34M36.05M104.97M(25.89M)87.59M
Other Working Capital00000
Other Non-Cash Items(47.09M)(31.41M)(60.34M)(67.76M)3.27M
Operating Cash Flow133.34M103.31M105.21M155.78M274.79M
Capital Expenditures(113.18M)(243.13M)(441.93M)(313.57M)(253.35M)
Acquisitions (Net)14.81M0(3.59M)(175K)1.79M
Purchases of Investments00000
Sales of Investments773K31K00241.09K
Other Investing Activities(4.32M)(7.95M)15.6M(7.44M)0
Investing Cash Flow(96.43M)(242.95M)(421.22M)(310.21M)(262.15M)
Debt Repayment(120.18M)(31.04M)172.57M27.91M41.38M
Common Stock Issued380.09M00169.77M0
Common Stock Repurchased00000
Dividends Paid(11.2M)(13.5M)(14.29M)(14.46M)(14.16M)
Other Financing Activities6.13M0(250K)0(6.03M)
Financing Cash Flow254.85M(44.54M)158.03M183.22M21.19M
Effect of Forex Changes3.68M1.88M(1.16M)(115K)10.11M
Net Change in Cash295.44M(182.3M)(159.14M)28.67M43.94M
Free Cash Flow20.16M(139.82M)(336.72M)(157.8M)21.44M

Stevanato Group S.p.A.

NYSE:STVN

Intrinsic Alpha fair value

Locked

Current Price

$15.36

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.